Bhagiradha Chemicals & Industries Ltd

Bhagiradha Chem. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bhagiradha Chemicals & Industries Ltd

₹ 1,171 3.03%
29 Mar - close price
bhagirad.com BSE: 531719 NSE : BHAGCHEM
About

Bhagiradha Chemicals & Industries is an Agro Chemical Company in India involved in the manufacturing of insecticides, fungicides, herbicides etc. It was Promoted by late Sri S. Koteswara Rao, a former scientist of Indian Institute of Chemical Technology, Hyderabad in the year 1993.[1][2]

Key Points

Product Portfolio
The company's product portfolio includes a wide range of insecticides, fungicides, herbicides, and specialty intermediaries -
a. Insecticides: Chlorpyrifos, Diafenthiuron, Fipronil, Buprofezin, etc.
b. Fungicides: Azoxystrobin
c. Herbicides: Imazethapyr, Clodinafop-propargyl, Cloquintocet-mexyl
d. Specialty-intermediaries: R-HPPA, 2,6-Dichloroaniline, etc [1]

Website BSE NSE
  • Market Cap ₹ 1,216 Cr.
  • Current Price ₹ 1,171
  • High / Low ₹ 1,726 / 736
  • Stock P/E 25.6
  • Book Value ₹ 283
  • Dividend Yield 0.26 %
  • ROCE 24.8 %
  • ROE 20.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 105% CAGR over last 5 years
  • Company's median sales growth is 26.0% of last 10 years

Cons

  • Promoter holding has decreased over last quarter: -0.92%
  • Promoter holding is low: 23.5%
  • Debtor days have increased from 55.5 to 80.9 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
23 34 61 90 69 97 98 99 100 138 122 132 126
26 33 55 76 57 83 83 83 84 117 102 111 106
Operating Profit -3 1 7 13 12 15 15 16 16 20 20 20 20
OPM % -13% 2% 11% 15% 17% 15% 15% 17% 16% 15% 16% 15% 16%
3 0 0 0 1 0 0 0 0 0 0 1 1
Interest 1 2 2 2 2 2 2 3 2 2 2 1 1
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2
Profit before tax -3 -2 3 10 9 10 11 12 12 17 16 18 17
Tax % 31% 39% 19% 33% 23% 28% 30% 27% 28% 34% 24% 29% 29%
Net Profit -2 -1 3 6 7 7 8 8 9 11 12 13 12
EPS in Rs -2.10 -1.41 2.50 6.15 6.88 7.24 7.41 8.16 8.70 10.60 11.51 12.03 11.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
59 68 146 174 220 152 203 183 384 246 318 436 517
59 69 136 164 209 148 191 172 343 229 271 367 437
Operating Profit 0 -0 10 11 11 4 11 12 41 17 47 68 80
OPM % 1% -1% 7% 6% 5% 3% 6% 6% 11% 7% 15% 16% 15%
1 1 0 1 1 1 2 -8 1 4 2 1 2
Interest 1 2 4 4 6 7 7 7 8 5 8 9 5
Depreciation 3 3 4 5 3 4 4 3 5 7 8 9 9
Profit before tax -3 -4 3 2 3 -5 3 -6 29 9 32 51 67
Tax % 103% 36% 32% 10% 17% 39% 61% 77% 37% 27% 27% 30%
Net Profit 0 -3 2 2 3 -3 1 -1 18 7 23 36 48
EPS in Rs 0.13 -4.55 3.18 3.16 4.06 -5.18 1.60 -1.35 17.76 6.32 22.78 34.85 45.76
Dividend Payout % 0% 0% 0% 26% 20% 0% 0% 0% 9% 0% 0% 7%
Compounded Sales Growth
10 Years: 20%
5 Years: 17%
3 Years: 4%
TTM: 31%
Compounded Profit Growth
10 Years: 29%
5 Years: 105%
3 Years: 25%
TTM: 46%
Stock Price CAGR
10 Years: 49%
5 Years: 37%
3 Years: 75%
1 Year: 34%
Return on Equity
10 Years: 11%
5 Years: 14%
3 Years: 14%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
5 5 5 5 5 5 5 8 8 8 8 8 10
Reserves 42 39 41 43 44 41 46 94 120 124 148 182 284
16 26 39 53 71 62 64 61 47 43 62 81 18
10 19 39 41 75 71 91 80 98 50 55 71 83
Total Liabilities 73 90 124 142 195 179 206 243 274 225 273 342 396
33 31 35 48 52 66 69 77 106 138 145 149 160
CWIP 1 3 12 9 16 0 0 0 4 4 1 3 4
Investments 0 0 0 0 0 0 0 0 0 0 8 9 20
39 56 77 85 127 113 138 166 164 83 119 181 211
Total Assets 73 90 124 142 195 179 206 243 274 225 273 342 396

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
12 -21 8 3 1 18 8 -27 49 48 4 6
-2 0 -17 -14 -15 -0 -6 -13 -38 -39 -21 -16
1 8 8 10 13 -17 -2 43 -12 -9 15 12
Net Cash Flow 10 -12 -0 -2 -1 1 -0 3 -1 0 -2 2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 57 99 89 71 82 67 31 71 80 17 68 81
Inventory Days 64 188 103 99 139 256 282 281 77 137 97 92
Days Payable 49 121 113 104 143 216 205 191 110 59 89 74
Cash Conversion Cycle 72 167 78 66 78 106 108 161 47 95 76 99
Working Capital Days 76 168 85 85 82 80 66 133 50 35 71 91
ROCE % -2% -4% 8% 7% 8% 0% 8% 7% 22% 7% 20% 25%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
24.90 24.90 24.90 24.90 24.90 24.90 24.90 24.90 24.90 24.57 24.44 23.52
2.41 2.41 2.89 2.89 2.89 2.41 2.06 1.08 0.89 0.43 0.20 0.10
72.69 72.69 72.21 72.21 72.21 72.69 73.04 74.02 74.21 75.01 75.35 76.39

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings